Serodominant SARS-CoV-2 Nucleocapsid Peptides Map to Unstructured Protein Regions

Keyphrases

• COVID-19 100%
• Peptide Map 100%
• Intrinsically Unstructured Protein 100%
• Epitope 66%
• COVID-19 Patients 66%
• Structural Mapping 66%
• Epitope Mapping 66%
• Antigenic Regions 66%
• Structural Biology 33%
• Linker Region 33%
• Clinical Outcomes 33%
• Patient Serum 33%
• Future Therapeutics 33%
• X-ray Structure 33%
• Immunogenic 33%
• State of the Field 33%
• Peptide Array 33%
• Therapeutic Design 33%
• Next-generation Vaccines 33%
• Antibody Response 33%
• Seroconversion 33%
• RNA-binding Domain 33%
• Intensive Care 33%
• Future Diagnostics 33%
• Structural Context 33%
• Improved Strategies 33%
• Viral Variants 33%
• Immunomodulatory Peptide 33%
• Amino Acid Variation 33%
• Viral Epitopes 33%
• Dimerization Domain 33%
• Epitope Region 33%
• Diagnostic Design 33%
• Impact Detection 33%
• N Protein 33%
• Prior Infection 33%
• Viral nucleocapsid Protein 33%
• Stable Domain 33%
• Structural Epitope 33%
• Overlapping Peptides 33%
• Protein Variation 33%
• Nucleocapsid (N) Protein 33%
• Variants of Concern 33%
• Anti-N Antibodies 33%
• Next-generation Diagnostics 33%

Immunology and Microbiology

• Severe Acute Respiratory Syndrome Coronavirus 2 100%
• Epitope 100%
• Virus Nucleocapsid 100%
• Peptides 100%
• COVID-19 50%
• Epitope Mapping 50%
• Antibody Response 25%
• X Ray 25%
• Seroconversion 25%
• Dimerization 25%
• RNA Recognition Motif 25%
• Amino Acid 25%

Biochemistry, Genetics and Molecular Biology

• Virus Nucleocapsid 100%
• SARS Coronavirus 100%
• Epitope Mapping 66%
• G Protein 66%
• X Ray 33%
• Dimerization 33%
• Genetics 33%
• Amino Acids 33%
• Antibody Response 33%
• Seroconversion 33%
• RNA Recognition Motif 33%